Health Condition 1: D180- Hemangioma
Conditions
Interventions
Intervention1: ICG Enhanced Transpupillary Therapy: ICG dye is given intravenously as a photosensitiser 2 min before Transpupillary Laser Therapy is initiated over the choroidal hemangioma
Control Int
Sponsors
AIIMS, New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Circumscribed choroidal hemangioma with tumor height less than 4mm and largest base diameter less than 10mm Presence of subretinal fluid on OCT less than 6mm in height Patients with subjective desire to receive treatment Patients with clear refractive media (not affecting laser treatment and follow up observations) Patients not undergoing any previous surgical or laser treatment and follow up observations.
Exclusion criteria
Exclusion criteria: Participants with age tumor height more than 4mm, LBD more than 10mm and SRF heigh more than 6mm Patients whose general conditions are not suitable to receive FFA/ICGA examination or laser treatment (pregnancy, breastfeeding women, patients with CKD on dialysis)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resorption of subretinal fluid, tumor response and visual acuity changesTimepoint: 1 month, 2 months, 3 months and 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare TTT with and without intravenous ICG dye injection and determine complicationsTimepoint: 4 months | — |
Countries
India
Contacts
Public ContactShivayan Srivastava
Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi
Outcome results
None listed